HOW TO DO IT?
Moderators:
Dr. Răzvan Curcă, Alba Iulia County Emergency Hospital
SL. Dr. Simona Volovăț, University of Medicine and Pharmacy "Grigore T. Popa", Iași
1. How to understand clinical trial designs
Dr. Joana Ribeiro, Gustave Roussy,
France
2. How to read and evaluate a clinical paper?
Phys. Anne Appelt, School of Medicine, University of Leeds, UK
3. How to write a PhD?
Assoc. Prof. Assia Konsulouva, Chief of Medical Oncology Clinic, National
Cancer Hospital, Sofia, Bulgaria
10:00
Coffee Break
10:15
Discussed Clinical Cases Session- SARCOMA, H&N CANCER
Dr. Raluca Pătru, Colțea Emergency Clinical Hospital, Bucharest
Dr. Silvia Moșoiu, Institute of Oncology “Prof. Dr. Alexandru Trestioreanu”, Bucharest
1. Center experience and personal view
Dr. Salvadore Provenzano,
IRCCS Istituto Nazionale dei Tumori, Milan, Italy
2. A journey of challenges: management of locally advanced leiomyosarcoma of the thigh
Assist. Univ. Dr. Vlad Afrăsânie, University of Medicine and Pharmacy "Grigore T. Popa", Iași
3. Dosimetric challenges in whole-lung radiotherapy for Ewing Sarcoma
Lecturer Dr. Radu Mitrică, Institute of Oncology “Prof. Dr. Alexandru Trestioreanu”, Bucharest
4. Treatment of locally advanced Hypopharyngeal cancer - clinical case
Dr. Olesya Stativko, City Clinical Oncology Hospital, Moscow, Russia
5. Metachronous cancer in laryngeal cancer
Dr. Bandol Geanina, Regional Institute of Oncology, Iași
11:45
Break
12:00
NAVIGATING CHALLENGES IN ONCOLOGY
Moderators:
Prof. Univ. dr. Șerban Negru, Oncohelp, Timișoara
Dr. Raluca Cîmpeanu, Emergency Clinical County Hospital, Craiova
1. Medical Communication in Oncology
Dr. Bogdan Neacșu, Târgu Lăpuș City Hospital
2. The preventive approach in malpractice
Av. Andrei Nicolau, SCPA PSBH Popescu, Nicolau & Asociații
3. Palliative care guidelines for patients with advanced gynecological cancers
Dr. Liliana Streba, University of Medicine and Pharmacy, Craiova
4. Burnout or the invisible danger
Psih. Iulia Băluțoiu, University of Medicine and Pharmacy, Craiova
5. Multimodal treatment options and physio-pathological mechanism of cancer anorexia-cachexia syndrome(CACS)
Bogdan Georgescu, Sanador Oncological Center, Bucharest
6. How should a clinical study be designed?
Assoc. Prof. Doru Paul, Weill Cornell Medicine, US
13:50
Lunch Break
14:40
Discussed Clinical Cases Session- BREAST CANCER
Moderators:
Dr. Dragoș Median, Filantropia Clinical Hospital, Bucharest
Dr. Ștefania Toma, Ponderas Academic Hospital, Bucharest
1. Translational research in HER2+ Breast Cancer: the GoBreast integrative
platform
Dr. Rodrigo Sanchez-Bayona, ESMO Young Oncologists Committee
member, Oncology Department- Breast Cancer Unit, Hospital Universitario 12 de
Octubre, Madrid, Spain
2. Beyond Chemotherapy: Exploring the Multimodal Approach to Treatment of Metastatic Triple Negative Breast Cancer
Lecturer. Dr. Cristian Lungulescu, University of Medicine and Pharmacy, Craiova
3. An intricate, long-term HER2 inhibition
Dr. Daniel Dulf, , Medisprof Cancer Center,
Cluj-Napoca
4. Planning of breast reconstruction in the management of
breast cancer
Dr. Codrin Dobreanu, Regional Institute of Oncology, Iași
5. Challenges and Solutions for Breast Cancer Radiotherapy
Dr. Adelina Brezae, Amethyst Radiotherapy Center, Alba-Iulia
16:10
Coffee Break
16:25
TIPS& TRICKS in Radiology for Young Oncologists
Moderators:
Prof. Univ. Dr. Ioana Gheonea, University of Medicine and Pharmacy, Craiova
Dr. Radu Serescu, Amethyst Radiotherapy Center, Bucharest
1. Imaging management of pulmonary nodular lesions in plain language
Dr. Cristina Ciofiac, University of Medicine and Pharmacy, Craiova
2. The contribution of modern imaging methods in the diagnosis of breast
and cervical cancer
Assist. Univ. Dr. Raluca Nica, University of Medicine and Pharmacy, Craiova
3. CT vs MRI in the diagnosis of hepatocellular carcinoma and rectal cancer
Lecturer. Dr. Lucian Florescu, University of Medicine and Pharmacy, Craiova
4. The role of the imaging physician in the multidisciplinary approach to the prostate cancer patient
Dr. Rossy Vlăduț Teică, University of Medicine and Pharmacy, Craiova
17:40
Break
17:50
THE IMPORTANCE OF TUMOR BOARD
Moderators:
Prof. Univ. Dr. Cornelia Nițipir, University of Medicine and Pharmacy “Carol Davila”, Bucharest
Dr. Lavinia Grigore, Elias Emergency University Hospital, Bucharest
1. What about comprehensive molecular testing in breast cancer? Sharing experience with Molecular Tumor Board, Breast Cancer Center
Chair Dr. Nicoleta Antone, Oncological Institute "Prof. Dr. Ion Chiricuță", Cluj-Napoca
Medical Oncology: Dr. Nicoleta Antone, Dr. Andrada Deac
Functional Genomics: CS I Ovidiu Bălăcescu
Anatomical Pathology: Dr. Bogdan Fetica
Genetics: Conf. Univ. Dr. Adrian Trifa
2. Clinical cases discussions in a multidisciplinary team
Chair Dr. Vlad Croitoru, Clinical Institute Fundeni, Bucharest
Medical Oncology: Assist. Univ. Dr. Irina Cazacu, Dr. Vlad Croitoru
Radiation Oncologist: Dr. Bogdan Chivu
Radiology: Dr. Iulia Grecu
Surgery: Dr. Șerban Spiratos
19:20
Closing Ceremony
Platform 2
20 May 2023
09:00
ORIGINAL PAPERS SESSION- Research
Moderators: Lecturer Dr. Mihai Marinca, University of Medicine and Pharmacy “Grigore T. Popa”, Iași
Assist. Univ. Dr. Andrada Deac, University of Medicine and Pharmacy "Iuliu Hațieganu", Cluj Napoca
1. Gene expression profiling in invasive lobular carcinoma of the breast
Dr. Domen Ribnikar- Slovenia
2. Addition of human chorionic gonadotropin to the current standard mobilization approach with granulocyte-colony stimulating factor increases overall survival in a murine model of peripheral blood stem cell transplantation. Are we far enough for therapy?
Dr. Andrei Cismaru, Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hațieganu” University of
Medicine and Pharmacy, Cluj-Napoca
3. Integrated data analysis of TCGA pan genomic cancer data reveals specific patterns of oncogenes and tumor suppressor genes in cancer evolution: a tumor stage related analysis
Dr. Cristina Ciocan, Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hațieganu” University of Medicine and
Pharmacy, Cluj-Napoca
4. In vitro antitumoral effects of cannabinoids in case of a metastatic breast cancer cell line
Dr. Ioana Creangă-Murariu, Grigore T. Popa” University of Medicine and Pharmacy Iași
5. NGS-from diagnosis to treatment
Assist. Univ. dr. Ana Maria Ciurea, University of Medicine and Pharmacy, Craiova
6. LncRNA-MALAT1 promotes triple-negative breast cancer cells to become resistant to therapy
Dr. Cornelia Braicu, Research Center for Functional Genomics, Biomedicine and Translational Medicine. “Iuliu Haíeganu” University of Medicine and Pharmacy Cluj-Napoca
7. Real-world data on second-line therapy with ramucirumab in metastatic gastric cancer: a two-center study on Romanian population
Dr. Diana Galoș, Oncological Institute "Prof. Dr. Ion Chiricuță", Cluj-Napoca
10:20
Coffee Break
10:35
Sponsored Symposia
10:35
-- MSD Symposia Long term excellence: Keytruda 5 Year Updates Keynote 189 & 407
Dr. Andra Meșter
11:05
-- Pfizer Symposia How RWE data accompany results from randomised clinical trials -P-Reality X Study
Lecturer Dr. Simona Volovăț
11:25
-- AstraZeneca Symposia Redefining unresectable HCC care
Dr. Andra Meșter
11:45
-- Lilly Symposia Cyramza - I’m ready to do what it takes
Vlad Croitoru
12:00
-- EWO Pharma Symposia ERIBULIN (HALAVEN®). A new option in metastatic breast cancer
Dr. Răzvan Curcă
12:15
Break
12:20
Sponsored Symposia
Novartis Symposia
Moderators: Dr. Daniel Ciurescu, Dr. Răzvan Curcă
12:20
Exploring the current landscape of CDK4/6 inhibitors
Dr. Lorenzo Gerratana
13:00
Shared experience session: Right time, right patient
Clinical benefit in advanced BC patients
Asist.Univ. Dr. Vlad Afrăsânie, Dr. Elena Dumitrescu, Dr. Amalia Roșu
13:40
Lunch Break
14:40
Sponsored Symposia
15:25
-- Ipsen Symposia Current management of advanced RCC
Dr. Silvia Brotea-Moșoiu
14:40
-- Gilead Symposia A new horizon for patients with mTNBC
Dr. Raluca Pătru
14:55
-- Lilly Symposia What sets Verzenios apart in CDK4/6 inhibitors class
Dr. Vlad Afrăsânieu
15:40
-- Sanofi Symposia Cemiplimab immunotherapy- from cutting-edge research to current practice
Dr. Bogdan Georgescu
16:10
Coffee Break
16:25
Sponsored Symposia
16:25
-- JnJ Symposia New approaches to patients with hormone-sensitive metastatic prostate cancer
Dr. Victor Nimirceag
16:45
-- AstraZeneca Symposia Understanding the Foundational Concepts of HER2-Low Breast Cancer
1. New Perspectives on the Full Spectrum of HER2 Expression in Breast Cancer
Dr. Bogdan Fetica
2. Navigating the HER2-Low Paradigm in Management of Breast Cancer Patients
Dr. Dragoș Median